TY - JOUR AU - Horvat, Natally AU - Ryan, Davinia E. AU - LaGratta, Maria D. AU - Shah, Pari M. AU - Do, Richard Kinh PY - 2017 TI - Imaging for pancreatic ductal adenocarcinoma JF - Chinese Clinical Oncology; Vol 6, No 6 (December 2017): Chinese Clinical Oncology (Pancreas Adenocarcinoma Part II Guest Editors: Eileen O’Reilly, Lei Zheng) Y2 - 2017 KW - N2 - Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide due to its aggressiveness and the challenge to early diagnosis. Complete surgical resection is the only curative option, but fewer than 20% of patients have potentially resectable disease at the time of the diagnosis. Radiologists can assess whether PDAC is resectable, borderline resectable, locally advanced or metastatic based on current imaging tests. This review will outline the role of imaging in both the diagnosis and staging of PDAC, with the goal of assisting the multidisciplinary team in tailoring the best treatment for patients. UR - http://cco.amegroups.com/article/view/17486